Analytical Data
-
Gene name
C7orf50
- Application
-
Alternative Names
C7orf50; CG050_HUMAN; Chromosome 7 open reading frame 50; Hypothetical Protein LOC84310; MGC11257; Uncharacterized Protein C7orf50; YCR016W
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BRJ6
-
Expression Region
1-194aa
-
AA Sequence
MAKQKRKVPE VTEKKNKKLK KASAEGPLLG PEAAPSGEGA GSKGEAVLRP GLDAEPELSP EEQRVLERKL KKERKKEERQ RLREAGLVAQ HPPARRSGAE LALDYLCRWA QKHKNWRFQK TRQTWLLLHM YDSDKVPDEH FSTLLAYLEG LQGRARELTV QKAEALMREL DEEGSDPPLP GRAQRIRQVL QLLS
-
Molecular Weight
48.5 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C7orf50, also known as Chromosome 7 Open Reading Frame 50, is a protein-coding gene implicated in various biological processes, including cellular function and disease mechanisms. Emerging studies have linked C7orf50 to critical roles in immunity, inflammation, and cell signaling pathways, highlighting its potential relevance in conditions such as autoimmune diseases and cancer. Despite its significance, the functional characterization of C7orf50 remains limited due to the lack of comprehensive studies and the complexity of its interactions within cellular environments. Recombinant protein production of C7orf50 has gained attention as a promising approach to elucidate its structure, function, and potential therapeutic applications. By employing advanced techniques in molecular biology, researchers aim to produce C7orf50 as a recombinant protein, enabling them to investigate its biochemical properties, binding interactions, and modulation of cellular pathways. Understanding the role of C7orf50 through recombinant protein studies could uncover novel insights into its involvement in health and disease, paving the way for the development of targeted therapies and biomarkers for early diagnosis. Thus, the exploration of C7orf50 recombinant protein represents a critical step in unraveling the functional dynamics of this gene and its contributions to various biological phenomena.
